在开发HDAC/Tubulin双重向抑制剂的最新进展
Christine Tran1, Abdallah Hamze1
1BioCIS, CNRS (Centre National de Recherche Scientifique), Université Paris-Saclay, 91400 Orsay, France.
Pharmaceuticals (Basel, Switzerland)
|March 27, 2025
概括
双向抑制剂结合基因组脱乙酶 (HDAC) 和氨酸抑制,显示出癌症治疗的前景. 这种方法提高了有效性,并减少了抗癌药物开发中的毒性和耐药性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 基因脱乙酶 (HDACs) 调节基因表达,细胞增殖和分化,使它们成为癌症的关键标.
- 微管对于细胞结构和功能至关重要,也是抗癌药物研究中的重要目标.
- 多目标疗法提供了一种提高抗瘤疗效和克服药物耐药性的策略.
研究的目的:
- 审查最近在HDACs和tubulin的双重向抑制剂方面的进展.
- 探索这些双重抑制剂对抗癌药物发现的影响.
- 为了突出结合HDAC和氨酸抑制的好处.
主要方法:
- 关于HDAC/图布林双抑制剂的近期研究 (过去十年) 的文献综述.
- 对双重向剂的协同效应和降低毒性的分析.
- 对抗癌症药物发现和开发的影响评估.
主要成果:
- 新型HDAC/图布林双抑制剂的开发已经取得显著进展.
- 这些双重抑制剂显示出协同作用的抗癌活性.
- 与单一向药物相比,联合抑制导致毒性和耐药性降低.
结论:
- 在癌症治疗中,HDAC/图布林双向抑制剂是一个有前途的策略.
- 这种方法优化治疗效果,并最大限度地减少不良影响.
- 对这些双重抑制剂的进一步研究对于推进抗癌药物发现至关重要.
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


